Synthetic lethality in p53 mutated B-cell mylignancies: Chk-1 inhibition and DNA-PK inhibition effect in cell lines and primary CLL cells

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	ZEMANOVÁ Jana ŠEBEJOVÁ Ludmila PARUCH Kamil HYLSE Ondřej POSPÍŠILOVÁ Šárka MAYER Jiří TRBUŠEK Martin
Year of publication	2013
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Related projects:	Časná identifikace CLL pacientů s dosud nevyselektovanými mutacemi v proteinu p53 Nové klinické a diagnostické přístupy u hematogických malignit